NFIL3C/EBP binding site 1 in the Zeb2 enhancer, located ~165 kb upstream, was targeted with sgRNAs (targeting ATACCCATGTTACATAATTA) and an ssODN template (CAAAATAGCAGAAAACCACAGCTGCTTGAGCAGTTAACAGATATCAGTAAAATACCCATGGCGGCCGCTTAAGGATAACGTTCTTGAAGCATATGGGCTGAAGGTATTATACTCTCATTAAAACTTTA) using CRISPR/Cas9 technology, resulting in the deletion of the binding site. (J:334296)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count